Iguratimod attenuates general disease activity and improves lung function in rheumatoid arthritis-associated interstitial lung disease patients

CONCLUSIONS: Iguratimod attenuates general inflammation, disease activity, and improves lung function in RA-ILD patients.PMID:34337716 | DOI:10.26355/eurrev_202107_26379
Source: Pharmacological Reviews - Category: Drugs & Pharmacology Authors: Source Type: research